ToveAlma@sciencebuzz.com'
Tove Alma



Experience

Content

  • Most Viewed
  • Most Liked

Tab 1

Engineering Biospecificity into a Single Albumin-Binding Domain

Monoclonal antibodies have been widely used in nearly all areas of life science for over three decades and represent a growing class of agents also in the clinics, mainly due to their generally high specificity and excellent pharmacokinetic properties. Today, regulatory authorities have approved over 20 monoclonal antibodies for therapeutic or diagnostic use.

Tab 2

Engineering Biospecificity into a Single Albumin-Binding Domain

Monoclonal antibodies have been widely used in nearly all areas of life science for over three decades and represent a growing class of agents also in the clinics, mainly due to their generally high specificity and excellent pharmacokinetic properties. Today, regulatory authorities have approved over 20 monoclonal antibodies for therapeutic or diagnostic use.

ALL ARTICLES

Engineering Biospecificity into a Single Albumin-Binding Domain

Monoclonal antibodies have been widely used in nearly all areas of life science for over three decades and represent a growing class of agents also in the clinics, mainly due to their generally high specificity and excellent pharmacokinetic properties. Today, regulatory authorities have approved over 20 monoclonal antibodies for therapeutic or diagnostic use.

CONTRIBUTIONS

  • Comments
  • Likes

Tab 3

Tab 4

Tab 5

Reviews
Scroll to top

Send this to a friend